| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |